Expanding Product Portfolio Combiphar offers a diverse range of over 200 prescription and over-the-counter products, including popular items like cough syrups, eye-care solutions, and supplements, presenting multiple cross-selling and up-selling opportunities across their product lines.

Regulatory Certifications The recent TGA certification for their manufacturing plant in West Java enables Combiphar to export selected products to Australia, indicating potential growth in international markets and opportunities for partners looking to expand into Southeast Asia and Oceania.

Modern Manufacturing & R&D With state-of-the-art production technology and an in-house R&D facility focusing on quality optimization and nanotechnology, Combiphar is positioned to innovate and develop high-value, differentiated products that could appeal to premium healthcare markets.

Strong Reputation and Loyalty Ranked as Indonesia’s second most reputable healthcare brand in 2015, Combiphar’s strong brand equity and customer loyalty create opportunities for partnerships that leverage their trusted position in the local healthcare space.

Health Campaign Engagement Their recent #JalanTerusIndonesia campaign symbolizing a focus on health and wellness engagement presents a platform for collaborations centered on health awareness initiatives, wellness programs, and community-driven marketing efforts.